Digital health technologies (DHT), including digital medication adherence monitoring, have the potential to revolutionize drug development, and must be given every opportunity to succeed. That’s according to the European Federation of Pharmaceutical Industries and Associations (EFPIA) reflection paper, which has … Read More
Company News
Pfizer Acknowledges the Need for Better Medication Adherence in Clinical Trials
Drug giant, Pfizer has highlighted the need for effective, patient-centered medication adherence management in clinical trials. Nothing stops a drug from working more than not taking it, but, as medicine and leadership pioneer and Pfizer’s Chief Medical Officer, said, non-adherence … Read More
AARDEX Group and BIOCORP Recruited by Trials@Home – Decentralized Trial Centre of Excellence
Combining BIOCORP’s pen injector add-on with AARDEX® Group’s Software to improve adherence to medication in a Hybrid Phase IV Diabetes Study. Liege, Belgium – July 19, 2022: Following the launch of their global collaboration to support medication adherence in different fields last … Read More
Why Patient Adherence Behaviours Should Be Common Knowledge in Clinical Trials
Realizing the potential of the revolution in cancer treatment depends on ensuring researchers, regulators, and clinicians have access to all the information they need to develop, approve, and prescribe new drugs – including patient adherence data. Nothing stops a drug … Read More
Smart Caps Improve Medication Adherence in Clinical Trials – It’s a Fact!
Poor medication adherence is a problem that has gone “unsolved” for decades. But combining smart caps with individualized feedback can drive the adherence that proves the investigational product efficacy and underwrites approvals. In this case study, we set out the … Read More
High Fidelity Measurement of Patients’ Medication Adherence: A Missing Link in Precision Medicine
The emergence of pharmacogenomics is an important milestone in the precision medicine journey – but the importance of measuring medicine adherence, an essential component in the complex pharmacokinetics/ pharmacodynamics equation, can often be overlooked. In this article, Bernard Vrijens, CEO … Read More
Clincal Trials and Tribulations Newsletter – May 2022 Edition
Welcome to the May edition of AARDEX Group’s Clinical Trials and Tribulations Newsletter – an aggregated collective of all of the industry’s hottest news and views! Breaking News New Pivotal Data Demonstrates the Clinical Benefit of Roche’s glofitamab, a Potential … Read More
In a world of outcome-based pricing, can you afford to neglect patient adherence?
The emergence of outcome-based contracts in clinical research has placed an additional consideration on the already thorny issue of adherence. When drug companies are paid according to the real-world effectiveness of their products, ensuring people take the medications as prescribed … Read More
Adherence to Medication: The Missing Piece in the Pharmacogenomics Puzzle
If enacted, the US’ Right Drug Dose Now Act will place pharmacogenomics on the main stage of drug development and move us further into the personalized medicine era. By supporting the use of pharmacogenetic testing to prevent adverse events (AEs) … Read More
Harnessing Smart Pill Bottles to Improve Patient Adherence in Clinical Research
“Nothing stops a drug from working like not taking it, making patient adherence one of the most important factors to consider when designing a clinical trial.” – Bernard Vrijens, Scientific Lead, AARDEX® Group Poor patient adherence is a problem that has … Read More